ArticleZeitschrift fur Gastroenterologie2025
[Position paper for the standardized use of transjugular intrahepatic portosystemic shunt (TIPS) in adults].
Article in Zeitschrift fur Gastroenterologie, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
32 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Portal hypertension is associated with significant morbidity and mortality. Liver cirrhosis accounts for up to 90 % of portal hypertension cases, while approximately 10 % are due to non-cirrhotic factors, including vascular liver diseases.This condition can lead to various complications, such as the development of gastroesophageal varices, which greatly increase the risk of variceal bleeding. Other common complications of portal hypertension include ascites and hepatorenal syndrome (HRS).The transjugular intrahepatic portosystemic shunt (TIPS) procedure is regarded as the most effective treatment for managing portal hypertension. Research shows that TIPS insertion can improve survival rates for patients with recurrent ascites, as well as for select individuals with refractory ascites and variceal bleeding. However, peri-interventional and post-interventional complications may pose challenges to the use of TIPS. Recent advancements in devices, techniques, and prophylactic medications aim to minimize the risk of complications following this procedure.This interdisciplinary position paper summarizes recommendations and guidance regarding patient selection, indications and contraindications, techniques, and follow-up care for patients undergoing TIPS in Germany.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.